Related Experiment Video
Updated: Sep 6, 2025

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Epigenetic Mechanisms Influencing Therapeutic Response in Breast Cancer
Amaia Arruabarrena-Aristorena1,2,3, Eneda Toska4,5
1Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain.
Abstract:
The majority of breast cancers are estrogen receptor (ER)+ and agents targeting the ER signaling pathway have markedly increased survival for women with breast cancer for decades. However, therapeutic resistance eventually emerges, especially in the metastatic setting. In the past decade disrupted epigenetic regulatory processes have emerged as major contributors to carcinogenesis in many cancer types. Aberrations in chromatin modifiers and transcription factors have also been recognized as mediators of breast cancer development and therapeutic outcome, and new epigenetic-based therapies in combination with targeted therapies have been proposed. Here we will discuss recent progress in our understanding of the chromatin-based mechanisms of breast tumorigenesis, how these mechanisms affect therapeutic response to standard of care treatment, and discuss new strategies towards therapeutic intervention to overcome resistance.
Insights
Estrogen receptor-positive breast cancer treatments face resistance. Epigenetic changes drive tumor growth and impact therapy effectiveness, necessitating new strategies to overcome resistance.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Most breast cancers are estrogen receptor-positive (ER+).
- Targeting ER signaling improves survival but resistance develops, particularly in metastatic disease.
- Epigenetic dysregulation is increasingly recognized in cancer development and progression.
Purpose of the Study:
- To review advances in understanding chromatin-based mechanisms in breast cancer.
- To explore how epigenetic alterations influence response to standard therapies.
- To discuss novel therapeutic strategies for overcoming treatment resistance.
Main Methods:
- Review of recent scientific literature on breast cancer epigenetics and therapy.
- Analysis of chromatin modifiers and transcription factors in tumorigenesis.
- Discussion of emerging epigenetic-based therapeutic approaches.
Main Results:
- Epigenetic regulatory processes are key contributors to breast cancer initiation and progression.
- Aberrant epigenetic mechanisms mediate resistance to endocrine therapies.
- Chromatin modifications impact the efficacy of standard breast cancer treatments.
Conclusions:
- Understanding epigenetic mechanisms is crucial for developing effective breast cancer therapies.
- Targeting epigenetic pathways offers a promising strategy to overcome therapeutic resistance.
- Combination therapies involving epigenetic agents and targeted treatments show potential for improved patient outcomes.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...

